Faeth Therapeutics Statistics
NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.88-0.81 (-9.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Faeth Therapeutics by the numbers
Faeth Therapeutics has a market capitalization of $203.7 million based on 25.84M shares outstanding. With trailing EPS of $-22.50, Faeth Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 64.3% below its 50-day average and 69.0% below its 200-day average.
Average daily trading volume is 500.25K shares, or about $3.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FTH valuation vs. peer median
| Metric | FTH | Peer median | Difference |
|---|---|---|---|
| Market cap | $203.65M | $199.89M | +2% |
| Avg. volume | 500.25K | 533.19K | -6% |
Peer median across 8 companies: BCYC, DRUG, VNDA, NGEN, CYPH, BIOA, YARW, ACIU.
Valuation
- Market cap
- $203.65M
- EPS (TTM)
- $-22.50
- Shares outstanding
- 25.84M
Price and trading
- Previous close
- 8.69
- Open
- 8.52
- Day range
- 7.85 – 9.13
- 52-week range
- 7.45 – 42.14
- 52-week change
- -9.64%
- Beta
- —
- Volume
- 419.09K
- Average volume
- 500.25K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 203.65M
- Forward Pe
- -2.15
- Eps
- -22.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.14
- Week52 Low
- 7.45
- Avg Volume
- 500.25K
- Shares Outstanding
- 25.84M
- Ma50
- 22.10
- Ma200
- 25.42
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -81.30%
- Pct From52w Low
- 5.77%